Speaker Interview with Dane Hartung

Dane Hartung, Director Marketing and Access, Fougera Pharmaceuticals shares best practices for determining if and when you should implement a new Commercial Patient Access Program. Dane also discusses how you should go about ensuring your early access program is ethical, compliant and effectively differentiates your product.

Please note: That all fields marked with an asterisk (*) are required.